Home > Insider Trading > Filing (0000899243-21-017486)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1630627	Treace Medical Concepts Inc.	TMCI	Surgical & Medical Instruments & Apparatus (3841)	471052611

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1856380	T. John Treace	C/O Treace Medical Concepts, Inc. 203 Fort Wade Rd., Suite 150 Ponte Vedra FL 32081	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-27	299,510	$0.00	11,171,385	No	4	C	Direct
Common Stock	Disposition	2021-04-27	5,253,805	$17.00	5,917,580	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Acquisiton	2021-04-27	6,932	$0.00	6,932	$0.00
Common Stock	Series A Preferred Stock	Disposition	2021-04-27	299,510	$0.00	299,510	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
299,510			No	4	J	Direct
0			No	4	C	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,605,000	Indirect	By Wife
Common Stock	1,471,250	Indirect	By Wife as co-trustee of the JTT Irrevocable Trust dated September 30, 2020
Common Stock	1,839,063	Indirect	As Trustee of the Tracy W. Treace Irrevocable Trust dated September 25, 2020

Footnotes

Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.
These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters.
The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.